Target intelligence / Profile preview

Polycystin-2-like 1 ion channel (PKD2L1)

Target
PKD2L1
Molecular classification
Ion channel, TRP (Transient Receptor Potential) channel subfamily P (TRPP), Cation channel
01

Overview

Polycystin-2-like 1 ion channel (PKD2L1) is a member of the TRP (transient receptor potential) ion channel superfamily, specifically the TRPP subfamily, encoded by the PKD2L1 gene. This protein forms a homotetrameric ion channel structure typical of TRP channels, featuring six transmembrane segments and a polycystin mucolipin domain. PKD2L1 is permeable to calcium and monovalent cations and is mainly localized to the primary cilia and plasma membrane of various cell types, where it participates in modulating ciliary calcium signaling and electrical activity. PKD2L1 shares significant sequence identity with polycystin-2 (PKD2), the product of which is implicated in autosomal dominant polycystic kidney disease (ADPKD), but unlike PKD2, no human diseases have been conclusively linked to PKD2L1 mutations. Functional studies in mice have shown that deletion of PKD2L1 leads only to mild developmental phenotypes. PKD2L1 is essential for specific calcium-dependent signaling in primary cilia and may contribute to chemosensation in certain neurons, like cerebrospinal fluid-contacting neurons[1][3]. No known drugs or selective modulators currently target this channel, and its value as a therapeutic target is currently considered exploratory.

Other names
Polycystin-2-like protein 1PKD2L1PKD2LPKDLTRPP3Polycystin-2L1PCLPolycystic kidney disease 2-like 1 proteinPolycystin-2 homologPolycystin-LPolycystin-L1transient receptor potential cation channel, subfamily P, member 3
02

Biological functions

Calcium and monovalent cation transportRegulation of intracellular calcium concentrationParticipation in electrical signaling in cilia and some neuronsInvolvement in primary cilia signaling pathways
03

Disease associations

Currently, no diseases are directly linked to PKD2L1 in humansMinor role reported in some mouse models related to gut malrotation and situs inversusBroader TRPP family implicated in ciliopathies and kidney disease, but PKD2L1 has not been shown to cause polycystic kidney disease in humans
04

Safety considerations

No significant safety concerns reported for therapeutic targeting, due to lack of disease linkage and known pharmacology

Beyond the preview

Go deeper on Polycystin-2-like 1 ion channel (PKD2L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polycystin-2-like 1 ion channel (PKD2L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call